Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2204]

FDA grants breakthrough designation to atezolizumab in combination with bevacizumab for advanced or metastatic HCC

FDA grants breakthrough designation to atezolizumab in combination with bevacizumab for advanced or metastatic HCC

American Cancer Society outlines blueprint for cancer control in the 21st century

American Cancer Society outlines blueprint for cancer control in the 21st century

American Cancer Society outlines blueprint for cancer control in the 21st century

American Cancer Society outlines blueprint for cancer control in the 21st century

Large population study fails to find causal link between assisted reproduction and ovarian cancer

Large population study fails to find causal link between assisted reproduction and ovarian cancer

Computer algorithm maps cancer resistance to drugs, therapy

Computer algorithm maps cancer resistance to drugs, therapy

Clinical care for transgender cancer patients starts with caring about transgender cancer patients

Clinical care for transgender cancer patients starts with caring about transgender cancer patients

Improved PSMA-targeting agent more effective for prostate cancer diagnosis/therapy in mice

Improved PSMA-targeting agent more effective for prostate cancer diagnosis/therapy in mice

Novel nuclear medicine approach shows promise for treating wide array of cancerous tumours

Novel nuclear medicine approach shows promise for treating wide array of cancerous tumours

FDA approves bevacizumab plus chemotherapy for women with advanced ovarian cancer following initial surgery

FDA approves bevacizumab plus chemotherapy for women with advanced ovarian cancer following initial surgery

Oncology clinical trials platform in development for Africa

Oncology clinical trials platform in development for Africa

More from ecancer